PMID: 9444520Jan 1, 1997Paper

Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate

Fundamental & Clinical Pharmacology
R Levent Büyükuysal

Abstract

Incubation of striatal slices with sodium nitroprusside (SNP) or hydroxylamine (HA) for 60 min caused a dose-dependent increase in dopamine (DA) release. This effect was inhibited completely by tetrodotoxin (TTX) (1 microM) if low concentrations of SNP (1 microM) or HA (10 and 100 microM) were tested. Although-higher concentration of SNP (10 and 100 microM) and HA (500 microM) were still effective in stimulating DA release, increases observed under these conditions were less than the values found in the absence of TTX. Verapamil (10 microM), but not omega-conotoxin (100 nM), significantly reduced DA release stimulated by high concentrations of SNP or HA. When verapamil was combined with TTX, moreover, SNP and HA failed to stimulate DA release. If striatal slices were incubated in the presence of nomifensine (10 microM), SNP and HA did not enhance DA release. SNP and HA-induced depletions in tissue DA levels were also protected by nomifensine. Inhibition of guanylate cyclase with 10 microM of methylene blue could not reduce the effects of NO-donors. SNP and HA also failed to alter endogenous glutamate release from striatal slices. Similarly, SNP and HA-induced increases in DA release were not affected by kynurenic acid and MK-80...Continue Reading

References

Jan 1, 1992·Neuron·D S Bredt, S H Snyder
May 27, 1992·European Journal of Pharmacology·H Prast, A Philippu
Sep 22, 1992·European Journal of Pharmacology·G LonartK M Johnson
Feb 1, 1991·Trends in Neurosciences·J Garthwaite
Nov 29, 1991·Science·M Barinaga
Oct 1, 1988·Trends in Neurosciences·R W TsienA P Fox
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Jan 1, 1984·The Journal of Membrane Biology·J R Clay, A Shrier
Oct 1, 1993·Trends in Neurosciences·G Levi, M Raiteri
Feb 1, 1994·Journal of Neurochemistry·R Guevara-GuzmanK M Kendrick
Jun 1, 1993·Journal of Neuroscience Research·G LonartK M Johnson
Sep 1, 1993·Neuron·D AttwellM Szatkowski

❮ Previous
Next ❯

Citations

Mar 2, 2006·European Journal of Anaesthesiology·U ErkentM Ilhan
Sep 4, 2016·Pharmacological Reviews·Daniel P Bermingham, Randy D Blakely
Feb 4, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J G P PiresH A Futuro Neto
Apr 22, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Henrike HartungStephanie J Cragg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.